The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic factors in stage 4 neuroblastoma treated with busulphan-melphalan: Report from the European HR-NBL1/Siopen trial.
 
Ruth Ladenstein
Honoraria - Apeiron Biologics; Boehringer Ingelheim
Consulting or Advisory Role - Apeiron Biologics; Boehringer Ingelheim
Research Funding - Apeiron Biologics (Inst)
Patents, Royalties, Other Intellectual Property - Apeiron Biologics (Inst)
Expert Testimony - Apeiron Biologics
Travel, Accommodations, Expenses - Apeiron Biologics
 
Ulrike Poetschger
No Relationships to Disclose
 
Martin Elliott
No Relationships to Disclose
 
Roberto Luksch
No Relationships to Disclose
 
Victoria Castel
No Relationships to Disclose
 
Isaac Yaniv
Travel, Accommodations, Expenses - Apeiron Biologics
 
Vassilios Papadakis
No Relationships to Disclose
 
Genevieve Laureys
No Relationships to Disclose
 
Josef Malis
No Relationships to Disclose
 
Walentyna Balwierz
No Relationships to Disclose
 
Ellen Ruud
No Relationships to Disclose
 
Per Kogner
No Relationships to Disclose
 
Henrik Schroeder
No Relationships to Disclose
 
Ana Forjaz De Lacerda
No Relationships to Disclose
 
Maja Beck Popovic
No Relationships to Disclose
 
Pavel Bician
No Relationships to Disclose
 
Miklos Garami
No Relationships to Disclose
 
Toby Trahair
No Relationships to Disclose
 
Andrew DJ Pearson
Honoraria - Boehringer Ingelheim; Genentech
Consulting or Advisory Role - Boehringer Ingelheim; Genentech
 
Dominique Valteau Couanet
No Relationships to Disclose